FDA 483 - Predictive Biotech, Inc. - June 11, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Predictive Biotech, a stem cell manufacturer in Salt Lake City, UT, was cited for significant deficiencies in its manufacturing processes for injectable umbilical cord and amniotic membrane products. The inspection revealed a lack of aseptic process validation, inadequate investigation of sterility failures, and insufficient donor screening and eligibility determination. These issues raise serious concerns regarding the sterility, quality, and safety of the distributed products.
ID · 3cf3ba2a-3052-41f6-ad56-6546a4d86077